Cargando…

Multisystemic Therapy for Adolescents With Poorly Controlled Type 1 Diabetes: Reduced diabetic ketoacidosis admissions and related costs over 24 months

OBJECTIVE—The study aim was to determine if multisystemic therapy (MST), an intensive home-based psychotherapy, could reduce hospital admissions for diabetic ketoacidosis (DKA) in youth with poorly controlled type 1 diabetes over 24 months. Potential cost savings from reductions in admissions were a...

Descripción completa

Detalles Bibliográficos
Autores principales: Ellis, Deborah, Naar-King, Sylvie, Templin, Thomas, Frey, Maureen, Cunningham, Phillippe, Sheidow, Ashli, Cakan, Nedim, Idalski, April
Formato: Texto
Lenguaje:English
Publicado: American Diabetes Association 2008
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2518338/
https://www.ncbi.nlm.nih.gov/pubmed/18566340
http://dx.doi.org/10.2337/dc07-2094
_version_ 1782158560142032896
author Ellis, Deborah
Naar-King, Sylvie
Templin, Thomas
Frey, Maureen
Cunningham, Phillippe
Sheidow, Ashli
Cakan, Nedim
Idalski, April
author_facet Ellis, Deborah
Naar-King, Sylvie
Templin, Thomas
Frey, Maureen
Cunningham, Phillippe
Sheidow, Ashli
Cakan, Nedim
Idalski, April
author_sort Ellis, Deborah
collection PubMed
description OBJECTIVE—The study aim was to determine if multisystemic therapy (MST), an intensive home-based psychotherapy, could reduce hospital admissions for diabetic ketoacidosis (DKA) in youth with poorly controlled type 1 diabetes over 24 months. Potential cost savings from reductions in admissions were also evaluated. RESEARCH DESIGN AND METHODS—A total of 127 youth were randomly assigned to MST or control groups and also received standard medical care. RESULTS—Youth who received MST had significantly fewer hospital admissions than control subjects (χ(2) = 11.77, 4 d.f., n = 127; P = 0.019). MST-treated youth had significantly fewer admissions versus their baseline rate at 6-month (P = 0.004), 12-month (P = 0.021), 18-month (P = 0.046), and 24-month follow-up (P = 0.034). Cost to provide MST was 6,934 USD per youth; however, substantial cost offsets occurred from reductions in DKA admissions. CONCLUSIONS—The study demonstrates the value of intensive behavioral interventions for high-risk youth with diabetes for reducing one of the most serious consequences of medication noncompliance.
format Text
id pubmed-2518338
institution National Center for Biotechnology Information
language English
publishDate 2008
publisher American Diabetes Association
record_format MEDLINE/PubMed
spelling pubmed-25183382009-09-01 Multisystemic Therapy for Adolescents With Poorly Controlled Type 1 Diabetes: Reduced diabetic ketoacidosis admissions and related costs over 24 months Ellis, Deborah Naar-King, Sylvie Templin, Thomas Frey, Maureen Cunningham, Phillippe Sheidow, Ashli Cakan, Nedim Idalski, April Diabetes Care Clinical Care/Education/Nutrition/Psychosocial Research OBJECTIVE—The study aim was to determine if multisystemic therapy (MST), an intensive home-based psychotherapy, could reduce hospital admissions for diabetic ketoacidosis (DKA) in youth with poorly controlled type 1 diabetes over 24 months. Potential cost savings from reductions in admissions were also evaluated. RESEARCH DESIGN AND METHODS—A total of 127 youth were randomly assigned to MST or control groups and also received standard medical care. RESULTS—Youth who received MST had significantly fewer hospital admissions than control subjects (χ(2) = 11.77, 4 d.f., n = 127; P = 0.019). MST-treated youth had significantly fewer admissions versus their baseline rate at 6-month (P = 0.004), 12-month (P = 0.021), 18-month (P = 0.046), and 24-month follow-up (P = 0.034). Cost to provide MST was 6,934 USD per youth; however, substantial cost offsets occurred from reductions in DKA admissions. CONCLUSIONS—The study demonstrates the value of intensive behavioral interventions for high-risk youth with diabetes for reducing one of the most serious consequences of medication noncompliance. American Diabetes Association 2008-09 /pmc/articles/PMC2518338/ /pubmed/18566340 http://dx.doi.org/10.2337/dc07-2094 Text en Copyright © 2008, DIABETES CARE Readers may use this article as long as the work is properly cited, the use is educational and not for profit, and the work is not altered. See http://creativecommons.org/licenses/by-nc-nd/3.0/ for details.
spellingShingle Clinical Care/Education/Nutrition/Psychosocial Research
Ellis, Deborah
Naar-King, Sylvie
Templin, Thomas
Frey, Maureen
Cunningham, Phillippe
Sheidow, Ashli
Cakan, Nedim
Idalski, April
Multisystemic Therapy for Adolescents With Poorly Controlled Type 1 Diabetes: Reduced diabetic ketoacidosis admissions and related costs over 24 months
title Multisystemic Therapy for Adolescents With Poorly Controlled Type 1 Diabetes: Reduced diabetic ketoacidosis admissions and related costs over 24 months
title_full Multisystemic Therapy for Adolescents With Poorly Controlled Type 1 Diabetes: Reduced diabetic ketoacidosis admissions and related costs over 24 months
title_fullStr Multisystemic Therapy for Adolescents With Poorly Controlled Type 1 Diabetes: Reduced diabetic ketoacidosis admissions and related costs over 24 months
title_full_unstemmed Multisystemic Therapy for Adolescents With Poorly Controlled Type 1 Diabetes: Reduced diabetic ketoacidosis admissions and related costs over 24 months
title_short Multisystemic Therapy for Adolescents With Poorly Controlled Type 1 Diabetes: Reduced diabetic ketoacidosis admissions and related costs over 24 months
title_sort multisystemic therapy for adolescents with poorly controlled type 1 diabetes: reduced diabetic ketoacidosis admissions and related costs over 24 months
topic Clinical Care/Education/Nutrition/Psychosocial Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2518338/
https://www.ncbi.nlm.nih.gov/pubmed/18566340
http://dx.doi.org/10.2337/dc07-2094
work_keys_str_mv AT ellisdeborah multisystemictherapyforadolescentswithpoorlycontrolledtype1diabetesreduceddiabeticketoacidosisadmissionsandrelatedcostsover24months
AT naarkingsylvie multisystemictherapyforadolescentswithpoorlycontrolledtype1diabetesreduceddiabeticketoacidosisadmissionsandrelatedcostsover24months
AT templinthomas multisystemictherapyforadolescentswithpoorlycontrolledtype1diabetesreduceddiabeticketoacidosisadmissionsandrelatedcostsover24months
AT freymaureen multisystemictherapyforadolescentswithpoorlycontrolledtype1diabetesreduceddiabeticketoacidosisadmissionsandrelatedcostsover24months
AT cunninghamphillippe multisystemictherapyforadolescentswithpoorlycontrolledtype1diabetesreduceddiabeticketoacidosisadmissionsandrelatedcostsover24months
AT sheidowashli multisystemictherapyforadolescentswithpoorlycontrolledtype1diabetesreduceddiabeticketoacidosisadmissionsandrelatedcostsover24months
AT cakannedim multisystemictherapyforadolescentswithpoorlycontrolledtype1diabetesreduceddiabeticketoacidosisadmissionsandrelatedcostsover24months
AT idalskiapril multisystemictherapyforadolescentswithpoorlycontrolledtype1diabetesreduceddiabeticketoacidosisadmissionsandrelatedcostsover24months